ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3069

Weight Loss in the Early Rheumatoid Arthritis Period Is Associated with Subsequent Increased Mortality in RA Patients and Matched Comparators: Evidence Against an RA-Specific Obesity Paradox

Jeffrey A. Sparks1, Shun-Chiao Chang2, Uyen Sa D.T. Nguyen3,4, Medha Barbhaiya2, Sara K. Tedeschi2, Bing Lu2, Karen H. Costenbader2, Yuqing Zhang5, Hyon K. Choi6 and Elizabeth W. Karlson2, 1Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 4Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology and Training Unit, Boston University School of Medicine, Boston, MA, 6Rheumatology, Allergy and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: morbidity and mortality, obesity, rheumatoid arthritis (RA) and weight loss

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Epidemiology and Public Health II: Obesity, Cancer and Mortality

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose : Weight loss may explain the obesity paradox for mortality, since those who unintentionally lose weight to reach normal BMI may have higher mortality than those with obesity and stable weight. A prior study among RA patients found an association between weight loss and increased mortality. However, weight was examined close to time of death in established RA without a non-RA comparison so the findings may not be specific to RA. Therefore, we investigated the association of weight change in the early RA period with subsequent mortality, and included a matched non-RA group to evaluate the influence of RA.

Methods : We identified incident RA by 1987 ACR criteria during follow-up of the Nurses’ Health Study (1976-2012) to form a cohort followed before and after RA onset. We created a comparison cohort by matching RA cases to non-RA comparators by age and year at the index date of RA diagnosis. Anthropometric, behavioral, and clinical data were collected through biennial questionnaires. To capture the entire early RA period, weight change was defined as the difference between weight at 4 years before and 4 years after RA diagnosis (“peri-RA”) or index date (“peri-index”). We used Cox regression to estimate HRs for mortality by weight change categories separately in each cohort. We combined both cohorts to evaluate the RA-specific effect and weight change on mortality.

Results : Among 121,700 women, we identified 875 subjects with incident RA, matched to 7,459 non-RA comparators. In the RA cohort, 16.2% lost >10 lbs peri-RA; 12.1% of comparators had weight loss >10 lbs peri-index. There were 243 (27.8%) deaths in the RA cohort and 1,369 (18.4%) deaths among comparators. After adjustment for BMI, smoking, diet, physical activity, comorbidities (cancer, CVD, and diabetes), erosions, serostatus, and nodules, weight loss >10 lbs peri-RA had HR for mortality of 1.61 (95%CI 1.12-2.32, Table), identical to the comparison cohort (HR 1.61, 95%CI 1.38-1.89). Weight gain was not significantly associated with mortality in either cohort. When combining both cohorts, RA had higher absolute mortality risk, but there was no interaction between RA or comparators with weight change for mortality (pint=0.86, Figure).

Conclusion : In this large prospective study with up to 36 years of follow-up, weight loss around RA diagnosis increased subsequent mortality risk among women. We found similar results in non-RA comparators and evaluated weight change in the early RA period when disease-specific processes are most likely to contribute to weight loss or gain. Therefore, an obesity paradox for mortality may occur in the general population but is not specifically related to RA.


Disclosure: J. A. Sparks, None; S. C. Chang, None; U. S. D. T. Nguyen, None; M. Barbhaiya, None; S. K. Tedeschi, None; B. Lu, None; K. H. Costenbader, UpToDate, 7; Y. Zhang, None; H. K. Choi, None; E. W. Karlson, None.

To cite this abstract in AMA style:

Sparks JA, Chang SC, Nguyen USDT, Barbhaiya M, Tedeschi SK, Lu B, Costenbader KH, Zhang Y, Choi HK, Karlson EW. Weight Loss in the Early Rheumatoid Arthritis Period Is Associated with Subsequent Increased Mortality in RA Patients and Matched Comparators: Evidence Against an RA-Specific Obesity Paradox [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/weight-loss-in-the-early-rheumatoid-arthritis-period-is-associated-with-subsequent-increased-mortality-in-ra-patients-and-matched-comparators-evidence-against-an-ra-specific-obesity-paradox/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/weight-loss-in-the-early-rheumatoid-arthritis-period-is-associated-with-subsequent-increased-mortality-in-ra-patients-and-matched-comparators-evidence-against-an-ra-specific-obesity-paradox/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology